Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications

British Journal of Dermatology, Supplement

Volumn 139, Issue 53, 1998, Pages 13-16

  Abeck, D ^a   Mempel, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; CLINDAMYCIN; CRYSTAL VIOLET; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; GLUCOCORTICOID; PENICILLIN DERIVATIVE; TRICLOSAN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CORTICOSTEROID THERAPY; HUMAN; ORAL DRUG ADMINISTRATION; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOPICAL DRUG ADMINISTRATION;

EID: 0032410073     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.1390s3013.x     Document Type: Review

References (31)

1. Zeisler J. Note on the antiparasitic treatment of eczema. J Cutan Genito-Urin Dis 1885; 13: 507-11.
2. Dahl MV. Staphylococcus aureus and atopic dermatitis. Arch Dermatol 1983; 119: 840-6.
3. Abeck D, Ruzicka T. Bacteria and atopic eczema. In: Handbook of Atopic Eczema (Ruzicka T, Ring J, Przybilla B, eds). Berlin: Springer. 1991; 212-20.
4. Aly R, Maibach HJ, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol 1977; 102: 128-37.
5. Leyden JL, Marples R, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1993; 90: 525-30.
6. Mempel M, Schmidt T, Weidinger St et al. Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J Invest Dermatol 1998; 111: 452-6.
7. Seidenari St, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol (Stockh) 1995; 75: 429-33.
8. Abeck D, Bleck O, Ring J. Skin barrier and eczema. In: New Trends in Allergy IV (Ring J, Behrendt H, Vieluf D, eds). Berlin: Springer, 1996; 213-20.
9. Bibel DJ, Aly R, Shinefield HR. Antimicrobial activity of sphingosines. J Invest Dermatol 1992; 98: 269-73.
10. Leung DYM, Harbeck R, Bina P et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. J Clin Invest 1993; 92: 1374-80.
11. McFadden JP, Noble WC, Camp RDR. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993; 128: 631-2.
12. Leung DYM, Travers JB, Norris DA. The role of superantigens in skin disease. J Invest Dermatol 1995; 105: 37S-42S.
13. Neuber K, Steinrücke K, Ring J. Staphylococcal enterotoxin B affects in vitro IgE synthesis, interferon-gamma, interleukin 4 and interleukin-5 production in atopic eczema. Int Arch Allergy Immunol 1995; 107: 179-82.
14. Ezepchuk YV, Leung DYM, Middleton MH et al. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol 1996; 107: 603-9.
15. Strange P, Skov L, Lisby S et al. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996; 132: 27-33.
16. Williams REA, Gibson AG, Aitchison TC et al. Assessment of contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol 1990; 123: 493-501.
17. Ring J, Brockow K, Abeck D. The therapeutic concept of 'patient management' in atopic eczema. Allergy 1996; 51: 206-15.
18. Lever R. Infection in atopic dermatitis. Derm Ther 1997; 1: 32-7.
19. Goncalves J, Thorn P. Fusidic acid and the treatment of patients with skin and soft tissue infections. Europ J Clin Res 1991; 1: 91-7.
20. Korting HC, Zienicke H, Braun-Falco O et al. Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: do prednicarbate and didecyldimethylammoniumchloride form a rational combination? Infection 1994; 22: 390-3.
21. Brockow K, Grabenhorst P, Traupe B et al. Gentian violet for the treatment of atopic eczema - antibacterial and clinical efficacy. J Invest Dermatol 1997; 109: 463.
22. Verbist L. The antimicrobial activity of fusidic acid. J Antimicrob Chemother 1990: 25 (Suppl. B): 1-5.
23. Simon C, Stille W. (Hrsg.) Antibiotika-Therapie in Klinik und Praxis. 9. Aufl., New York, Stuttgart: Schattauer, 1997.
24. Speller DCE, Johnson AP, James D et al. Resistance to methicillin and other antibiotics in isolates of Staphylococus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997; 350: 323-5.
25. 4) on bacterial skin flora in atopic dermatitis. Acta Derm Venereol (Stockh) 1992; 176: 132-4.
26. Gehring W, Forssman Th, Jost G, Gloor M. Die keimreduzierende Wirkung von Erythromycin und Triclosan bei der atopischen Dermatitis. Akt Dermatol 1996; 22: 28-31.
27. Krutman J. Phototherapy for atopic dermatitis. Derm Ther 1996; 1: 24-31.
28. Yoshimura M, Namura S, Akamatsu H, Horio T. Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol 1996; 135: 528-32.
29. Schempp Chr, Effinger Th, Czech W et al. Charakterisierung von Non-Respondern bei der hochdosierten UVA1-Therapie der akut exazerbierten atopischen Dermatitis. Hautarzt 1997; 48: 94-9.
30. Kaplan SS, Lancaster JR, Basford RE, Simmons RL. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun 1996; 64: 69-76.
31. Leroy BP, Boden G, Lachapelle J-M et al. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 1993; 28: 232-9.